ConductScience.org, home

Paper9720515

Prognostic markers in bladder cancer: a contemporary review of the literature.

Stein JP and 7 others. J Urol, 1998. Cited by 231 papers, by iCite.

Cite this record

ConductScience Library. Prognostic markers in bladder cancer: a contemporary review of the literature. Papers, record 9720515. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9720515

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic markers in bladder cancer: a contemporary review of the literature.
PubMed
Journal
J Urol
PubMed
Year
1998
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
231
iCite
Relative citation ratio, by iCite
6.44
iCite
Revised in PubMed
2023-03-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Stein JPJ P
2Grossfeld GDG D
3Ginsberg DAD A
4Esrig DD
5Freeman JAJ A
6Figueroa AJA J
7Skinner DGD G
8Cote RJR J

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, Transitional CellMajor topic
Urinary Bladder NeoplasmsMajor topic
Antigens, Neoplasm
Biomarkers, Tumor
Cell Adhesion Molecules
Cell Cycle Proteins
Epidermal Growth Factor
Forecasting
Humans
Neovascularization, Pathologic
Oncogenes
Prognosis

Source PubMed

Download CSV of topics

Cited by39

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 231 citations.

PMIDTitleJournalYearIn PapersSource
39628486Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?Front Immunol2024https://conductscience.org/library/papers/39628486PubMed
30112441Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study.Bladder Cancer2018https://conductscience.org/library/papers/30112441PubMed
29671787Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma.Int J Mol Sci2018https://conductscience.org/library/papers/29671787PubMed
29667104Fruit and vegetable intake and the risk of recurrence in patients with non-muscle invasive bladder cancer: a prospective cohort study.Cancer Causes Control2018https://conductscience.org/library/papers/29667104PubMed
28260746Inhibition of T24 and RT4 Human Bladder Cancer Cell Lines by Heterocyclic Molecules.Med Sci Monit2017https://conductscience.org/library/papers/28260746PubMed
27440446Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway.Cancer Sci2016https://conductscience.org/library/papers/27440446PubMed
26955879Clarification of the molecular pathway of Taiwan local pomegranate fruit juice underlying the inhibition of urinary bladder urothelial carcinoma cell by proteomics strategy.BMC Complement Altern Med2016https://conductscience.org/library/papers/26955879PubMed
26279824New and contemporary markers of prognosis in nonmuscle invasive urothelial cancer.Korean J Urol2015https://conductscience.org/library/papers/26279824PubMed
25866762Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis.Biomed Res Int2015https://conductscience.org/library/papers/25866762PubMed
25521854Met in urological cancers.Cancers (Basel)2014https://conductscience.org/library/papers/25521854PubMed
25391391Immunological basis in the pathogenesis and treatment of bladder cancer.Expert Rev Clin Immunol2015https://conductscience.org/library/papers/25391391PubMed
24359437Suppression of urinary bladder urothelial carcinoma cell by the ethanol extract of pomegranate fruit through cell cycle arrest and apoptosis.BMC Complement Altern Med2013https://conductscience.org/library/papers/24359437PubMed
24353313Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells.Mol Pharmacol2014https://conductscience.org/library/papers/24353313PubMed
23653844Evaluating the expression of oct4 as a prognostic tumor marker in bladder cancer.Iran J Basic Med Sci2012https://conductscience.org/library/papers/23653844PubMed
22207109Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells.Med Sci Monit2012https://conductscience.org/library/papers/22207109PubMed
21881030A randomized controlled trial of celecoxib to prevent recurrence of nonmuscle-invasive bladder cancer.Cancer Prev Res (Phila)2011https://conductscience.org/library/papers/21881030PubMed
20803103Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma.Med Oncol2011https://conductscience.org/library/papers/20803103PubMed
19707309Targeted therapies in the management of metastatic bladder cancer.Biologics2007https://conductscience.org/library/papers/19707309PubMed
19591789Comparative analysis of protein-protein interactions in cancer-associated genes.Genomics Proteomics Bioinformatics2009https://conductscience.org/library/papers/19591789PubMed
19228380Expression of Bmi-1 is a prognostic marker in bladder cancer.BMC Cancer2009https://conductscience.org/library/papers/19228380PubMed

See all 39 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9720515

GET https://conductscience.org/api/papers/v1/9720515/cited_by?page=2